Interest of Nutritional Care of Children With Sickle Cell Disease on Bone Mineral Density and Body Composition
NCT04754711 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 72
Last updated 2025-04-17
Summary
This study is design to assess the effects of an increase in nutritional intake on the bone mineral density of children with sickle cell disease, for 12 months.
Conditions
- Sickle Cell Disease
- Osteoporosis
- Osteopenia
Interventions
- DIETARY_SUPPLEMENT
-
Oral Nutritional Supplement
We will propose to the patients of group 1 several different oral nutritional supplements according to taste, and consistency of each child in order to optimize observance. Each of those different oral nutritional supplements will be adapted to the nutritional survey and the age of children without exceeding recommended intake of proteins, carbohydrates, lipids and micronutrients. Those patients will consume the Oral Nutritional Supplement during 12 months.
Sponsors & Collaborators
-
Centre Hospitalier Régional d'Orléans
lead OTHER
Principal Investigators
-
Georges DIMITROV, Dr · CHR d'Orléans
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 3 Years
- Max Age
- 16 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-09-23
- Primary Completion
- 2025-03-17
- Completion
- 2025-03-17
Countries
- France
Study Locations
More Related Trials
-
Dense Red Blood Cells in Sickle Cell Children
NCT02887118 ·Status: TERMINATED
-
Sleep Respiratory Disorders Evaluation in Sickle Cell Disease Children
NCT01565954 ·Status: COMPLETED
-
HLA Haploidentical Bone Marrow Transplant in Patients With Severe Sickle Cell Disease
NCT03240731 ·Status: COMPLETED ·Phase: PHASE2
-
Exercise Capacity in Pediatric Sickle Cell Anemia
NCT01527799 ·Status: COMPLETED
-
Effect of NUV001 Supplementation in Patients Suffering From Sickle Cell Disease (SCD)
NCT05789355 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Dietary Intake and Dietary Behaviors in Adults With Sickle Cell Disease
NCT05170412 ·Status: RECRUITING
-
Predictors and Outcomes in Patients With Sickle Cell Disease
NCT03431935 ·Status: COMPLETED
-
Longitudinal Changes in Exercise Capacity in Children and Young Adults With Sickle Cell Anemia
NCT01558076 ·Status: COMPLETED
-
Sickle Cell Disease (SCD) Bone Pain Study
NCT05283148 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Telemedicine for Children With Sickle Cell Disease
NCT05087303 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Exploration of the Parameters Influencing the Effort Limitation of Patients Suffering From Homozygous Sickle Cell Anemia
NCT06743139 ·Status: COMPLETED
-
Safety and Efficacy of Orally Administered NUV001 Nutraceutical Supplement in Sickle Cell Disease Patients
NCT05791591 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Hydroxyurea to Prevent Brain Injury in Sickle Cell Disease
NCT01389024 ·Status: COMPLETED ·Phase: PHASE2
-
Preliminary Feasibility and Efficacy of Behavioral Intervention to Reduce Pain-Related Disability in Pediatric SCD
NCT04388241 ·Status: COMPLETED ·Phase: NA
-
Low Systemic/High Local Exercise Load in Peds SCD
NCT06387758 ·Status: RECRUITING ·Phase: NA
-
Quality of Care of Children With Sickle Cell Disease (SCD) Screened at Birth in France
NCT03119922 ·Status: COMPLETED
-
Observational Study to Deeply Phenotype Major Organs in Sickle Cell Disease After Curative Therapies
NCT05213572 ·Status: RECRUITING
-
Evaluation of Therapeutic Adherence to Inciting Spirometry in Sickle Cell Patients
NCT04667325 ·Status: COMPLETED
-
Evaluation of Efficacy of Zoledronic Acid in Patients With Haemoglobin Syndromes (Thalassemia and Sicle Cell Anaemia) and Risk of Skeletal Events
NCT00346242 ·Status: COMPLETED ·Phase: PHASE4
-
Pharmacokinetics, Pharmacodynamics and Safety of Epeleuton in Patients With Sickle Cell Disease
NCT05861453 ·Status: COMPLETED ·Phase: PHASE2
-
Antioxidant Therapy to Reduce Inflammation in Sickle Cell Disease
NCT01054768 ·Status: COMPLETED ·Phase: PHASE2
-
Haploidentical Bone Marrow Transplantation in Sickle Cell Patients (BMTCTN1507)
NCT03263559 ·Status: COMPLETED ·Phase: PHASE2
-
Neuropsychological Studies of Children With Sickle Cell
NCT00005438 ·Status: COMPLETED
-
Study of the Effect of Etavopivat on Cerebral Hemodynamic Response in Children With Sickle Cell Disease
NCT05725902 ·Status: COMPLETED ·Phase: PHASE2
-
Bone Loss, Physical Function and Frailty in Older Women With Sickle Cell Trait Sickle Cell Trait
NCT07083531 ·Status: RECRUITING